Institut Mutualiste Montsouris — Biomedical Watch V2

Traitements2programmes

Essais1liés

Publications0liées

SourceDBlocale

Traitements

2

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
HIFU hemi-ablation combined with ADT.The current study aims to examine the hypothesis that combining the focal effects of HIFU with the systemic effects of androgen deprivation therapy might eradicate the prostatic cancer cells by targeting the 'visible' index focus (by HIFU) and the tumour surrounding microenvironment which may contain 'invisible' foci and aberrant PCa related signalling (by androgen deprivation therapy) to enhance oncological outcomes of HIFU hemi-ablation in men with localized PCa, and consequently reducing treatment failures.	Cancer	Phase 2	À vérifier	France	À vérifier
HIFU hemi-ablation combined with ADT.The current study aims to examine the hypothesis that combining the focal effects of HIFU with the systemic effects of androgen deprivation therapy might eradicate the prostatic cancer cells by targeting the 'visible' index focus (by HIFU) and the tumour surrounding microenvironment which may contain 'invisible' foci and aberrant PCa related signalling (by androgen deprivation therapy) to enhance oncological outcomes of HIFU hemi-ablation in men with localized PCa, and consequently reducing treatment failures.	Cancer	Phase 2	À vérifier	France	À vérifier

Essais cliniques

1

Molécule	Indication / population	Phase	NCT	Titre	Statut
HIFU hemi-ablation combined with ADT.	Cancer	Phase 2	NCT03845751	EvaluatioN of HIFU Hemiablation and Short Term AndrogeN Deprivation Therapy Combination to Enhance Prostate Cancer Control.	UNKNOWN

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.